Austar Lifesciences Ltd. (HK:6118) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Austar Lifesciences Ltd. has completed the acquisition of a 51% equity interest in a target company for $1.515 million, making it a wholly-owned subsidiary. This strategic move is aimed at enhancing market competitiveness and operational efficiency, as well as reducing costs by integrating resources within the group. The acquisition is expected to bolster Austar’s financial performance by leveraging the existing partnership with STERIS.
For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.